Table 2.
Bivariable Associations Between Risk Factors and New–Onset Disability at Discharge in the Derivation Cohort
Risk Factor | New–Onset Disability at Discharge* | P-Value† | |
---|---|---|---|
n (%) | Odds Ratio (95% Confidence Interval) | ||
Sociodemographic risk factor | |||
Age | <.001 | ||
70–79 | 114 (21) | 1.0 (ref) | |
80–89 | 108 (37) | 2.2 (1.6–3.1) | |
≥90 | 30 (60) | 5.7 (3.1–10.4) | |
Sex | <.01 | ||
Male | 86 (24) | 1 | |
Female | 166 (32) | 1.5 (1.1–2.1) | |
Marital status | <.001 | ||
Other | 27 (33) | 1 | |
Married | 83 (21) | 0.5 (0.3–0.9) | |
Widowed | 142 (35) | 1.1 (0. 7–1.8) | |
Self-identified race | .45 | ||
Black | 25 (25) | 1 | |
White | 227 (29) | 1.2 (0.8–1.9) | |
Education, years | .08 | ||
<12 | 100 (30) | 1 | |
12 | 58 (22) | 0.7 (0.5–1.0) | |
>12 | 64 (30) | 1.0 (0.7–1.5) | |
Lives alone | .18 | ||
No | 146 (27) | 1 | |
Yes | 105 (31) | 1.2 (0.9–1.7) | |
Functional status 2 weeks before admission | |||
Mobility | <0.001 | ||
Able to run a short distance | 38 (14) | 1 | |
Able to walk uphill or stairs but unable to run a short distance | 145 (30) | 2.6 (1.7–3.8) | |
Unable to walk uphill or stairs | 67 (48) | 5.5 (3.4–8.9) | |
Instrumental ADLs | <.001 | ||
Independent in all | 125 (21) | 1 | |
Dependent in 1–2 | 72 (35) | 2.0 (1.4–2.9) | |
Dependent in ≥3 | 55 (67) | 7.7 (4.6–12.6) | |
Characteristics on admission | |||
Patient assessment of global health | .40 | ||
Poor to fair | 63 (29) | 1 | |
Good, very good, or excellent | 123 (25) | 0.9 (0.6–1.2) | |
ADLs | <.001 | ||
Independent in all | 99 (19) | 1 | |
Dependent in 1 | 32 (27) | 1.6 (1.0–2.5) | |
Dependent in 2 | 39 (44) | 3.4 (2.1–5.5) | |
Dependent in 3 | 27 (47) | 3.8 (2.2–6.7) | |
Dependent in 4 or 5 | 52 (66) | 8.4 (5.0–14.1) | |
Number of depressive symptoms (Center for Epidemiologic Studies Depression Scale), n (%) | .75 | ||
0–3 | 185 (29) | 1 | |
≥4 | 67 (28) | 1.0 (0.7–1.3) | |
Gait | <.01 | ||
Steady | 47 (16) | 1 | |
Unsteady | 93 (26) | 1.8 (1.2–2.7) | |
Clinical conditions | |||
Stroke | <.001 | ||
Absent | 217 (26) | 1 | |
Present | 35 (63) | 4.7 (2.7–8.3) | |
Severe cognitive impairment | <.001 | ||
Absent | 162 (22) | 1 | |
Present | 90 (60) | 5.2 (3.6–7.5) | |
Congestive heart failure | .04 | ||
Absent | 179 (27) | 1 | |
Present | 73 (34) | 1.4 (1.0–2.0) | |
Peripheral vascular disease | .09 | ||
Absent | 179 (27) | 1 | |
Present | 73 (33) | 1.3 (1.0–1.9) | |
Pneumonia | .04 | ||
Absent | 229 (30) | 1 | |
Present | 23 (20) | 0.6 (0.4–1.0) | |
Chronic lung disease | .03 | ||
Absent | 198 (30) | 1 | |
Present | 54 (23) | 0.7 (0.5–1.0) | |
Gastrointestinal bleeding | .77 | ||
Absent | 237 (29) | 1 | |
Present | 15 (27) | 0.9 (0.5–1.7) | |
Diabetes mellitus | .53 | ||
Absent | 198 (29) | 1 | |
Present | 54 (27) | 0.9 (0.6–1.3) | |
Metastatic cancer | .03 | ||
Absent | 230 (28) | 1 | |
Present | 22 (42) | 1.9 (1.1–3.3) | |
Acute Physiology and Chronic Health Evaluation Acute Physiology Score (tertiles) | <.001 | ||
≤8 | 100 (24) | 1 | |
9–11 | 78 (26) | 1.1 (0.8–1.5) | |
>11 | 74 (43) | 2.4 (1.6–3.5) | |
Charlson comorbidity score (tertiles) | .02 | ||
0–1 | 93 (25) | 1 | |
2–3 | 93 (29) | 1.2 (0.9–1.7) | |
≥4 | 66 (36) | 1.7 (1.2–2.5) | |
Laboratory values | |||
Creatinine, mg/dL (tertiles) | .59 | ||
<1.5 | 194 (28) | 1 | |
1.5–2.9 | 44 (31) | 1.1 (0.8–1.7) | |
≥3 | 11 (36) | 1.4 (0.7–3.0) | |
Hematocrit, % (tertiles) | .1 | ||
<30 | 45 (33) | 1 | |
30–35 | 75 (32) | 0.9 (0.6–1.5) | |
≥36 | 127 (26) | 0.7 (0.5–1.0) | |
Serum albumin, g/dL | <.001 | ||
≥3.0 | 178 (26) | 1 | |
<3.0 | 64 (50) | 3.0 (2.0–4.4) |
The composite outcome of disabled at discharge includes participants with activity of daily living (ADL) disability and those who died during hospitalization, as described in the Methods section.
P-value from global likelihood ratio tests for each single predictor logistic regression model.